Search Results

Repotrectinib 25 mg  | 99.86%

TargetMol

Repotrectinib (TPX-0005) is a potent ALK/ROS1/TRK inhibitor, with IC50 of 1.01 nM, 5.3 nM, 1.08 nM and 1.26 nM for WT ALK, SRC, ALK L1196M and ALK G1202R, respectively.

More Information Supplier Page

Repotrectinib 10 mg  | 99.86%

TargetMol

Repotrectinib (TPX-0005) is a potent ALK/ROS1/TRK inhibitor, with IC50 of 1.01 nM, 5.3 nM, 1.08 nM and 1.26 nM for WT ALK, SRC, ALK L1196M and ALK G1202R, respectively.

More Information Supplier Page

CAY10602 5 mg  | 98.87%

TargetMol

CAY10602 is a SIRT1 activator. CAY10602 was derived from high throughput screening for compounds that increase SIRT1-mediated deacetylation of a SIRT1-specific substrate. Functional assays show that CAY10602 dose-dependently suppresses the NF-κB-dependent induction of TNF-α by lipopolysaccharide in THP-1 cells, with approximately 75% inhibition achieved at 60 μM, without cytotoxicity.

More Information Supplier Page

CAY10602 50 mg  | 98.87%

TargetMol

CAY10602 is a SIRT1 activator. CAY10602 was derived from high throughput screening for compounds that increase SIRT1-mediated deacetylation of a SIRT1-specific substrate. Functional assays show that CAY10602 dose-dependently suppresses the NF-κB-dependent induction of TNF-α by lipopolysaccharide in THP-1 cells, with approximately 75% inhibition achieved at 60 μM, without cytotoxicity.

More Information Supplier Page

ML329 5 mg  | Purity Not Available

TargetMol

ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.

More Information Supplier Page

ML329 50 mg  | Purity Not Available

TargetMol

ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.

More Information Supplier Page

ML329 25 mg  | Purity Not Available

TargetMol

ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.

More Information Supplier Page